Richter Axel, Niedergethmann Marco, Sturm Jörg W, Lorenz Dietmar, Post Stefan, Trede Michael
Department of Surgery, University-Hospital Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer, 68167, Mannheim, Germany.
World J Surg. 2003 Mar;27(3):324-9. doi: 10.1007/s00268-002-6659-z. Epub 2003 Feb 27.
The prognosis of patients who undergo resection for pancreatic ductal adenocarcinoma with curative intention is generally poor unless they have early-stage disease. Based on our 25-year experience, the results of 194 patients after a standardized Kausch-Whipple resection for adenocarcinoma of the pancreatic head were analyzed and the prognostic factors were evaluated. Between 1972 and 1998 a total of 221 patients were diagnosed for ductal adenocarcinoma of the pancreatic head, and 194 of them subsequently underwent a standardized Kausch-Whipple resection. Long-term results and prognostic factors were examined by multivariate and univariate analyses. The overall postoperative mortality was 3.09%, and the morbidity was 29.9%. By multivariate analysis only curative resection (R0) was significantly related to a favorable prognosis ( p < 0.0001). Furthermore, in case of a curative resection, the presence of lymph node metastases showed prognostic significance in the multivariate analysis ( p = 0.005). Cumulative survival analysis revealed a 5-year survival rate of 25.4%, a 7-year survival rate of 12.3%, and a 10-year survival rate of 8.2% for patients who underwent curative resection (R0) for adenocarcinoma of the pancreatic head. We demonstrated that the R0 status is the only independent prognostic factor after surgery for adenocarcinoma of the pancreatic head. In the case of a curative resection, the presence of lymph node metastases is of prognostic relevance. In view of considerable surgical morbidity and mortality, resection for cancer of the pancreatic head is the only option if the lesion is resectable. We concluded that surgical treatment is "as good as it gets," as extended techniques have not proved to produce better results.
以治愈为目的接受胰腺导管腺癌切除术的患者,其预后通常较差,除非处于疾病早期。基于我们25年的经验,对194例因胰头腺癌接受标准化考施-惠普尔切除术的患者结果进行了分析,并评估了预后因素。1972年至1998年间,共有221例患者被诊断为胰头导管腺癌,其中194例随后接受了标准化考施-惠普尔切除术。通过多变量和单变量分析检查长期结果和预后因素。术后总死亡率为3.09%,发病率为29.9%。多变量分析显示,只有根治性切除(R0)与良好预后显著相关(p<0.0001)。此外,在根治性切除的情况下,多变量分析显示淋巴结转移的存在具有预后意义(p=0.005)。累积生存分析显示,接受胰头腺癌根治性切除(R0)的患者5年生存率为25.4%,7年生存率为12.3%,10年生存率为8.2%。我们证明,R0状态是胰头腺癌手术后唯一的独立预后因素。在根治性切除的情况下,淋巴结转移的存在具有预后相关性。鉴于手术有相当高的发病率和死亡率,如果病变可切除,胰头癌切除术是唯一的选择。我们得出结论,手术治疗“已臻最佳”,因为扩大手术技术并未证明能产生更好的结果。